Record #54898
The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy-Induced Thrombocytopenia
Publisher
Original paper date
Jul 14, 2022
Original DOI
Country
Institution
Open access
No
Article type
Notes from Retraction Watch
See also: https://pubpeer.com/publications/CDEE706AB0C6B4B0554A578CF8115B
Citation lifecycle
How this paper is being cited
Pre-retraction
2
Same day
1
Post-retraction
0
% post-retraction
0.0%
~2.0 citations/yr before retraction · ~0.0 citations/yr after
— citing papers
Who is still citing this work
Loading…